Knoxville Kidney Center, PLLC
Knoxville, Tennessee, United States
Nephrologist in Knox County, Tennessee
320 Park 40 N Blvd, Knoxville, TN 37923
About Knoxville Kidney Center, PLLC
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
4
Pfizer
4
Gilead Sciences
2
Ardelyx
1
Bayer
1
Christopher Granger, MD
1
Eli Lilly and Company
1
Inversago Pharma Inc.
1
Ironwood Pharmaceuticals, Inc.
1
KBP Biosciences
1
Novome Biotechnologies Inc
1
Clinical Trials at Knoxville Kidney Center, PLLC
During the past decade, Knoxville Kidney Center, PLLC conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 12 clinical trials were completed, i.e. on
average, 63.2% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 5 clinical trials were completed. i.e. 45.5%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin
2012-01-17
2014-02-28
Completed
320
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
2012-07-01
2016-12-01
Completed
577
A Phase 3, Long-Term Safety Study of Subcutaneous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME -Anemia Management With Epoetin
2012-05-31
2015-02-13
Completed
170
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
2012-09-01
2015-03-01
Completed
435
Efficacy, Safety, and Tolerability of Selonsertib (GS-4997) in Participants With Diabetic Kidney Disease
2014-06-01
2016-08-01
Completed
334
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
2015-08-01
2019-05-01
Completed
696
A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis
2015-07-13
2016-07-16
Completed
432
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
2016-12-01
2019-08-12
Completed
154
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Knoxville Kidney Center, PLLC" #1 sponsor was "Boehringer Ingelheim" with 4 trials, followed by "Pfizer" with 4 trials
sponsored, "Gilead Sciences" with 2 trials sponsored, "Ardelyx" with 1 trials sponsored and "Bayer"
with 1 trials sponsored. Other sponsors include 7 different institutions and
companies that sponsored additional 17 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Knoxville Kidney Center, PLLC"
#1 collaborator was "Hospira, now a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator, "Medpace, Inc." with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Knoxville Kidney Center, PLLC
According to Clinical.Site data, the most researched conditions in "Knoxville Kidney Center, PLLC" are
"Chronic Kidney Disease" (4 trials), "Diabetic Kidney Disease" (4 trials), "Chronic Kidney Disease (CKD)" (3 trials), "Chronic Kidney Diseases" (2 trials) and "Diabetic Nephropathies" (2 trials). Many other conditions were trialed in "Knoxville Kidney Center, PLLC" in a lesser frequency.
Clinical Trials Intervention Types at Knoxville Kidney Center, PLLC
Most popular intervention types in "Knoxville Kidney Center, PLLC" are "Drug" (21 trials), "Biological" (5 trials), "Other" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (13 trials), "BI 685509" (3 trials), "Epoetin Hospira" (2 trials), "BI 690517" (1 trials) and "Dulaglutide" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Knoxville Kidney Center, PLLC
The vast majority of trials in "Knoxville Kidney Center, PLLC" are
24 trials for "All" genders.
Clinical Trials Status at Knoxville Kidney Center, PLLC
Currently, there are NaN active trials in "Knoxville Kidney Center, PLLC".
undefined are not yet recruiting,
7 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 13 completed trials in Knoxville Kidney Center, PLLC,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Knoxville Kidney Center, PLLC, 4 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 11 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".